Title: SB 675 Text
Official Title: 
Number of Sections: 1
Source: versions - Introduced Version
Media Type: text/html

================================================================================

Section 1:
SB 675 Text skip navigation SENATE PRESIDENT SENATORS COMMITTEES VIDEO/AUDIO DISTRICT MAPS SENATE CLERK SENATE RULES HOUSE SPEAKER DELEGATES COMMITTEES VIDEO/AUDIO DISTRICT MAPS HOUSE CLERK HOUSE RULES HOUSE STAFF JOINT INTERIM COMMITTEES LEGISLATIVE ADMINISTRATOR LEGISLATIVE SERVICES DIVISION PUBLIC INFORMATION LEGISLATIVE AUTOMATED SYSTEMS DIVISION LEGISLATIVE AUDITOR'S OFFICE PERFORMANCE EVALUATION & RESEARCH DIVISION POST AUDIT DIVISION BUDGET DIVISION REGULATORY AND FISCAL AFFAIRS DIVISION CLAIMS COMMISSION CRIME VICTIMS RULE-MAKING REVIEW SPECIAL INVESTIGATIONS JUDICIAL COMP. COMMISSION JOINT RULES STAFF INFO BILL STATUS BILL STATUS BILL TRACKING STATE LAW WEST VIRGINIA CODE ACTS OF THE LEGISLATURE CODE OF 1931 WV CONSTITUTION US CONSTITUTION REPORTS AGENCY REPORTS AGENCY GRANT AWARDS PERFORMANCE EVALUATIONS POST AUDITS EDUCATIONAL CITIZEN’S GUIDE INTERNSHIP PROGRAM PAGE PROGRAM PUBLICATIONS PHOTO GALLERY CAPITOL HISTORY HOW A BILL BECOMES LAW CONTACT SENATE ROSTER HOUSE ROSTER PUBLIC INFO. NEWS RELEASES HELPFUL LINKS Introduced Version Senate Bill 675 History |  Email Key: Green = existing Code. Red = new code to be enacted WEST VIRGINIA LEGISLATURE2025 REGULAR SESSIONIntroducedSenate Bill 675By Senators Rucker, Azinger, Roberts, Rose, Thorne, and Woelfel[Introduced March 4, 2025; referred to the Committee on Government Organization]A BILL to amend the Code of West Virginia, 1931, as amended, by adding a new section, designated §30-5-37, relating to requiring a participant in a federal 340B Drug Pricing Program to report certain data to the Board of Pharmacy.Be it enacted by the Legislature of West Virginia: ARTICLE 5. PHARMACISTS, PHARMACY TECHNICIANS, PHARMACY INTERNS AND PHARMACIES. §30-5-37. 340B Drug Pricing Program Reporting. (a) As used in this section, "340B covered entity" means an entity authorized to participate in the federal 340B Drug Pricing Program under Section 340B(a)(4) of the federal Public Health Service Act (42 U.S.C. 256b(a)(4)) and includes any pharmacy under contract with the entity to dispense drugs on behalf of the entity.(b) Before April 1 of each year, a 340B covered entity shall report the following information to the board concerning the 340B covered entity's participation in the federal 340B Drug Pricing Program for the previous calendar year: (1) The name of the 340B covered entity. (2) The aggregate acquisition cost for prescription drugs obtained under the 340B program. (3) The aggregate payment amount received for drugs obtained under the 340B program and dispensed to patients. (4) The aggregate payment made to pharmacies under contract to dispense drugs obtained under the 340B program. (5) The number of claims for prescription drugs described in subdivision (3). (6) How the 340B covered entity uses any savings from participating in the 340B program, including the amount of savings used for the provision of charity care, community benefits, or a similar program of providing unreimbursed health care to the indigent. (7) How the patients of the 340B covered entity who qualify for reduced medications are obtaining reduced price medications.(c) The information required to be reported under subsection (a) must be reported by payer type, including the following: (1) Commercial.(2) Medicaid. (3) Medicare. (d) The data submitted in the reports required under subsection (a) is confidential and is not available for public inspection pursuant to the provisions of §29B-1-1 et seq. (e) Before November 15 of each year, the West Virginia Board of Pharmacy shall prepare a report that at a minimum aggregates the data submitted under subsection (a) and analyzes how the covered entity uses any savings from participating in the 340B program including how the savings are used for the provision of charity care, community benefits, or a similar program of providing unreimbursed health care to the indigent and: (1) Submit the report to the Joint Committee of Government and Finance and the Joint Standing Committee on Insurance and PEIA; and (2) Post the report on the West Virginia Board of Pharmacy’s website. NOTE: The purpose of this bill is to require a participant in a federal 340B Drug Pricing Program to report certain data to the Board of Pharmacy.Strike-throughs indicate language that would be stricken from a heading or the present law and underscoring indicates new language that would be added. Bill Status  | Bill Tracking  | Legacy WV Code  | Bulletin Board  | District Maps  | Senate Roster  | House Roster  | Live  | Blog  | Jobs  | Links  | Home This Web site is maintained by the West Virginia Legislature's Office of Reference & Information.  | Terms of Use | Webmaster | © 2025 West Virginia Legislature ** Print On Demand Name: Email: Phone:


================================================================================

Raw Text:
SB 675 Text skip navigation SENATE PRESIDENT SENATORS COMMITTEES VIDEO/AUDIO DISTRICT MAPS SENATE CLERK SENATE RULES HOUSE SPEAKER DELEGATES COMMITTEES VIDEO/AUDIO DISTRICT MAPS HOUSE CLERK HOUSE RULES HOUSE STAFF JOINT INTERIM COMMITTEES LEGISLATIVE ADMINISTRATOR LEGISLATIVE SERVICES DIVISION PUBLIC INFORMATION LEGISLATIVE AUTOMATED SYSTEMS DIVISION LEGISLATIVE AUDITOR'S OFFICE PERFORMANCE EVALUATION & RESEARCH DIVISION POST AUDIT DIVISION BUDGET DIVISION REGULATORY AND FISCAL AFFAIRS DIVISION CLAIMS COMMISSION CRIME VICTIMS RULE-MAKING REVIEW SPECIAL INVESTIGATIONS JUDICIAL COMP. COMMISSION JOINT RULES STAFF INFO BILL STATUS BILL STATUS BILL TRACKING STATE LAW WEST VIRGINIA CODE ACTS OF THE LEGISLATURE CODE OF 1931 WV CONSTITUTION US CONSTITUTION REPORTS AGENCY REPORTS AGENCY GRANT AWARDS PERFORMANCE EVALUATIONS POST AUDITS EDUCATIONAL CITIZEN’S GUIDE INTERNSHIP PROGRAM PAGE PROGRAM PUBLICATIONS PHOTO GALLERY CAPITOL HISTORY HOW A BILL BECOMES LAW CONTACT SENATE ROSTER HOUSE ROSTER PUBLIC INFO. NEWS RELEASES HELPFUL LINKS Introduced Version Senate Bill 675 History |  Email Key: Green = existing Code. Red = new code to be enacted WEST VIRGINIA LEGISLATURE2025 REGULAR SESSIONIntroducedSenate Bill 675By Senators Rucker, Azinger, Roberts, Rose, Thorne, and Woelfel[Introduced March 4, 2025; referred to the Committee on Government Organization]A BILL to amend the Code of West Virginia, 1931, as amended, by adding a new section, designated §30-5-37, relating to requiring a participant in a federal 340B Drug Pricing Program to report certain data to the Board of Pharmacy.Be it enacted by the Legislature of West Virginia: ARTICLE 5. PHARMACISTS, PHARMACY TECHNICIANS, PHARMACY INTERNS AND PHARMACIES. §30-5-37. 340B Drug Pricing Program Reporting. (a) As used in this section, "340B covered entity" means an entity authorized to participate in the federal 340B Drug Pricing Program under Section 340B(a)(4) of the federal Public Health Service Act (42 U.S.C. 256b(a)(4)) and includes any pharmacy under contract with the entity to dispense drugs on behalf of the entity.(b) Before April 1 of each year, a 340B covered entity shall report the following information to the board concerning the 340B covered entity's participation in the federal 340B Drug Pricing Program for the previous calendar year: (1) The name of the 340B covered entity. (2) The aggregate acquisition cost for prescription drugs obtained under the 340B program. (3) The aggregate payment amount received for drugs obtained under the 340B program and dispensed to patients. (4) The aggregate payment made to pharmacies under contract to dispense drugs obtained under the 340B program. (5) The number of claims for prescription drugs described in subdivision (3). (6) How the 340B covered entity uses any savings from participating in the 340B program, including the amount of savings used for the provision of charity care, community benefits, or a similar program of providing unreimbursed health care to the indigent. (7) How the patients of the 340B covered entity who qualify for reduced medications are obtaining reduced price medications.(c) The information required to be reported under subsection (a) must be reported by payer type, including the following: (1) Commercial.(2) Medicaid. (3) Medicare. (d) The data submitted in the reports required under subsection (a) is confidential and is not available for public inspection pursuant to the provisions of §29B-1-1 et seq. (e) Before November 15 of each year, the West Virginia Board of Pharmacy shall prepare a report that at a minimum aggregates the data submitted under subsection (a) and analyzes how the covered entity uses any savings from participating in the 340B program including how the savings are used for the provision of charity care, community benefits, or a similar program of providing unreimbursed health care to the indigent and: (1) Submit the report to the Joint Committee of Government and Finance and the Joint Standing Committee on Insurance and PEIA; and (2) Post the report on the West Virginia Board of Pharmacy’s website. NOTE: The purpose of this bill is to require a participant in a federal 340B Drug Pricing Program to report certain data to the Board of Pharmacy.Strike-throughs indicate language that would be stricken from a heading or the present law and underscoring indicates new language that would be added. Bill Status  | Bill Tracking  | Legacy WV Code  | Bulletin Board  | District Maps  | Senate Roster  | House Roster  | Live  | Blog  | Jobs  | Links  | Home This Web site is maintained by the West Virginia Legislature's Office of Reference & Information.  | Terms of Use | Webmaster | © 2025 West Virginia Legislature ** Print On Demand Name: Email: Phone: